CARLY MADEEN: Open Payments
NPI 1114780491 · STARKVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,111 in 62 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $687 · 2025 $1,111
Food & beverage: $1,011Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $265 |
| Galderma Laboratories, L.P. | 14 | $211 |
| Janssen Biotech, Inc. | 4 | $141 |
| LEO Pharma Inc. | 5 | $97 |
| Regeneron Healthcare Solutions, Inc. | 5 | $88 |
| Organon LLC | 6 | $72 |
| E.R. Squibb & Sons, L.L.C. | 3 | $58 |
| GENZYME CORPORATION | 1 | $42 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| Incyte Corporation | 2 | $33 |
Products named: SKYRIZI, NEMLUVIO, TREMFYA, DUPIXENT, RINVOQ, VTAMA, Sotyktu, DYSPORT.
Industry payments across MS — which companies pay providers there.
